The latest advances in medicine are increasingly leading to the adoption of new minimally invasive therapies and procedures. In this respect, Endoret®(prgf®) has opened new paths and therapeutic approaches thanks to its accessibility and reparative capacity.
Endoret®(prgf®) is applicable in many fields of medicine, where its high level of efficiency in the regeneration of different tissues has been proven: bone, skin, oral mucosa, tendons, ligaments, muscles, cartilage, cornea, covering all medical specialities such as: oral and maxillofacial surgery, orthopaedics and sports medicine, dermatology, ophthalmology, vascular surgery, plastic and cosmetic surgery and even veterinary surgery.
The field of medicine that pioneered the use of Endoret®(prgf®).
Top-level sports players and personalities have benefitted from its effects.
An alternative to the healing of wounds that have difficulty scarring and an innovative treatment that achieves a very natural facial rejuvenation.
Initial advances in ophthalmology with excellent results..
At BTI we are carrying out important research and making an enormous clinical effort to develop new formulations and protocols for the application of Endoret®(prgf®) with the aim of improving the treatment of a wide range of clinical situations.
Intended for international use only. Indications for use of products and/or therapies contained herein may not be cleared /approved for use by the following Health international agencies: US Food & Drug Administration, Health Canada or Japanese Health Ministry. To access the specific information of your market, use the country selector located on the top menu of this page.